Get 30% off on all global market reports with code ONLINE30 – stay updated on tariff changes, macroeconomic trends, and more!
How Has the Upstream Bioprocessing Market Size Evolved Over the Last Few Years?
In recent times, the upstream bioprocessing market has expanded expeditiously. The market size is projected to escalate from $12.03 billion in 2024 to $13.62 billion in 2025, with a Compound Annual Growth Rate (CAGR) of 13.3%. The historic growth surge is attributed to the increasing need for process optimization and the contamination-free, efficient, and safe production of biomolecules. The market’s expansion is further propelled by the commercial success and growing demand for bio-therapeutics, the implementation rise of process analytical technology, the increasing prevalence of chronic diseases, and ramped up research into biosimilar production.
The market for upstream bioprocessing is forecasted to experience a swift expansion in the coming years. It is projected to reach $21.78 billion by 2029, with a compound annual growth rate of 12.4%. The predicted growth during this period can be linked to the commercial application of single-use bioreactors, the increase in outsourcing biopharmaceutical manufacturing, the accelerated expansion of the pharmaceutical and biotechnology sectors, the rising trend of adopting single-use upstream bioprocessing, and an upsurge in the number of partnerships, mergers, acquisitions, and collaborations. Notable trends for the forecast period include escalating investments in R&D within the biopharmaceutical sector, advances in technology, modern upstream bioprocessing technologies, and the evolution of new technologies alongside advanced filtration technologies.
Claim Your Free Sample Report:
http://www.thebusinessresearchcompany.com/sample….p;type=smp
What’s Driving the Upward Growth Trajectory of the Upstream Bioprocessing Market?
Growth in the upstream bioprocessing market is expected to be influenced by an increased in biopharmaceutical manufacturing outsourcing. Essentially, this involves certain aspects of the manufacturing process being handed over to third parties like contract manufacturing organizations (CMOs) or contract development and manufacturing organizations (CDMOs).
This strategy enhances cost efficiency, core specialization, scalability in production, specialized knowledge, and risk mitigation. By relying on external resources, product development in the upstream bioprocessing market speeds up, increases efficiency, and reduces expenditure. Data from BDO USA, a member of BDO International in the US, suggests that by 2025, around 44% of global mammalian capacity – an estimated 7,500kL – will be controlled by CDMOs and hybrid manufacturing firms. Consequently, the upstream bioprocessing market is experiencing growth due to the increased outsourcing of biopharmaceutical manufacturing.
Which Segments in the Upstream Bioprocessing Industry Are Seeing the Fastest Growth?
The upstream bioprocessingmarket covered in this report is segmented –
1) By Product type: Bioreactors; Fermenters; Cell Culture Media; Filters; Bags And Containers
2) By Workflow: Media Preparation; Cell Culture; Cell Separation
3) By Usage type: Single-Use; Multi-Use
4) By Mode: In House; Outsourced
5) By End User: Contract Development and Manufacturing Organization (CDMOs) Or Contract Research Organization (CROs); Research And Academic Institutes; Biopharmaceutical Companies
Subsegments:
1) By Bioreactors: Single-Use Bioreactors; Multi-Use Bioreactors
2) By Fermenters: Laboratory Fermenters; Pilot Scale Fermenters; Industrial Fermenters
3) By Cell Culture Media: Powdered Media; Liquid Media
4) By Filters: Sterile Filters; Air Filters; Capsule Filters
5) By Bags And Containers: Single-Use Bags; Bioprocess Containers; Storage Bags
Access the Full Report Today:
http://www.thebusinessresearchcompany.com/report/…ket-report
How Will Shifting Market Trends Influence Upstream Bioprocessing System Adoption?
Key players in the upstream bioprocessing industry are concentrating on the innovation of sophisticated bioreactors that cater to the requirements of cell culture operations, enhancing productivity, adaptability, and scalability. Such bioreactors serve a crucial function in upstream bioprocessing, facilitating a productive and regulated manufacturing of biopharmaceuticals through cell culture and biosynthesis procedures. For instance, Cytiva, an American company specializing in life science products and solutions, launched X-platform bioreactors in April 2023. These are designed to make single-use upstream bioprocessing easier. The bioreactors are composed of a cabinet assembly, a tank, along with a human-machine interface (HMI), ensuring flexible configurations without the need for specialized equipment or disposable bags. More user-oriented features constitute a fully opening door and improved cable management in an optimized vessel, as well as baffles. Moreover, the Bioreactor Scaler tool available online aids in establishing ideal parameters for successful scale-up.
Which Global Regions Are Powering Demand in the Upstream Bioprocessing Market?
North America was the largest region in the upstream bioprocessing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the upstream bioprocessing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Get a Customized Version of the Report:
http://www.thebusinessresearchcompany.com/customi…p;type=smp
How Key Players Are Driving Growth in the Upstream Bioprocessing Market?
Major companies operating in the upstream bioprocessing market are Thermo Fisher Scientific Inc., Danaher Corp, Merck KGaA, GE HealthCare Technologies, Parker Hannifin Corp, Corning Inc., AGC Biologics, Avantor, AGC Inc., Boehringer Ingelheim International GmbH, Catalent Inc., Sartorius AG, Entegris Inc., Getinge AB, Bio-Rad Laboratories Inc., Samsung Biologics Co. Ltd., Eppendorf AG, Repligen Corporation, Takara Bio Inc., KBI Biopharma Inc., Rentschler Biopharma SE, Just Biotherapeutics Inc., PBS Biotech Inc., Stobbe Group, Applikon Biotechnology
Access the Complete Report:
http://www.thebusinessresearchcompany.com/purchas…x?id=15950
How Our Market Research Reports Help Maximize ROI Across Industries:
* Identify High-Growth Opportunities: Pinpoint emerging trends, untapped segments, and regional hotspots that align with your strategic goals.
* Reduce Investment Risk: Make data-driven decisions with confidence by understanding market dynamics, key drivers, and competitive threats.
* Optimize Strategic Planning: Align your product development, marketing, and expansion plans with industry forecasts and customer behaviour insights.
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
News From
The Business Research Company …
Category: Industry Reports & Market Analysis Profile: The Business Research Company is a leading market research and consulting services provider. It offers over 9,500 market reports across 27 industries in 60+ geographies, providing detailed insights and forecasts. Its customised research solutions support companies in making critical decisions, while its continuous research service enhances organizational capabilities. The flagship Global Market Model database provides comprehensive market intelligence with 1,500,000 datasets covering 8,000+ mark …
This email address is being protected from spambots. You need JavaScript enabled to view it.
